Imaging features of typical usual interstitial pneumonia (UIP) von Escalon, J G, Lynch, D A

Volltext

Prenatal diagnosis of Aicardi-Goutières syndrome von Garrec, M. Le, Doret, M., Pasquier, J. C., Till, M., Lebon, P., Buenerd, A., Escalon, J., Gaucherand, P.

Volltext

Oncoplastic technics with nipple-areolar complex resection for the treatment of central breast cancers von Faure, C, Escalon, J, Brémond, A, Mignotte, H, Pérol, D, Delay, E

Volltext

Impact parental de l’échographie 3D/4D des fentes labiopalatines von Escalon, J., Huissoud, C., Bisch, C., Gonnaud, F., Fichez, A., Rudigoz, R.-C.

Volltext

7000 ORAL A phase I/II study to determine the feasibility and efficacy of the triple combination of Oblimersen (OBL), Abraxane (ABX), and Temozolomide (TMZ) in metastatic melanoma von Pavlick, A, Volm, M, Ryan, T, Escalon, J, Lee, L, Liebes, L

Volltext

Oxaliplatin With Weekly Bolus Fluorouracil and Low-Dose Leucovorin as First-Line Therapy for Patients With Colorectal Cancer von HOCHSTER, Howard, CHACHOUA, Abraham, SPEYER, James, ESCALON, Juliette, ZELENIUCH-JACQUOTTE, Anne, MUGGIA, Franco

Volltext

Chirurgie oncoplastique pour le traitement des tumeurs mammaires centrales von Faure, C., Escalon, J., Brémond, A., Mignotte, H., Pérol, D., Delay, E.

Volltext

Chirurgie oncoplastique pour le traitement des tumeurs mammaires centrales: Chirurgie oncoplastique du sein von FAURE, C, ESCALON, J, BREMOND, A, MIGNOTTE, H, PEROL, D, DELAY, E

Volltext

Hair depigmentation as an indicator of durable response to CTLA-4 therapy von Pavlick, A. C., Ott, P. A., Kannan, R., Madden, K. M., Sorlie, C., Escano, C., Escalon, J., Hernando-Monge, E., Osman, I., Bhardwaj, N.

Volltext

Survival of advanced melanoma patients with normal LDH treated with oblimersen, temozolomide, and nab-paclitaxel von Pavlick, A. C., Ott, P., Escalon, J., Madden, K., Yepes, E., Staha, J., Mendoza, S., Gandhi, A., Yee, H., Liebes, L.

Volltext

Comparison of the immunogenicity of Montanide ISA 51 adjuvant and cytokine-matured dendritic cells in a randomized controlled clinical trial of melanoma vaccines von O'Neill, D. W., Adams, S., Goldberg, J. D., Escalon, J. B., Rolnitzky, L. M., Cruz, C. M., Angiulli, A., Old, L., Pavlick, A. C., Bhardwaj, N.

Volltext

Parental impact of 3D/4D ultrasonography in fetal cleft lip and palate von Escalon, J, Huissoud, C, Bisch, C, Gonnaud, F, Fichez, A, Rudigoz, R-C

Volltext

Phase II trial of sorafenib (S [BAY 43–9006]) in metastatic melanoma (MM) including detection of BRAF with mutant specific-PCR (MS-PCR) and altered proliferation pathways-final out... von Min, C. J., Liebes, L. F., Escalon, J., Hamilton, A., Yee, H., Buckley, M. T., Wright, J. J., Osman, I., Polsky, D., Pavlick, A. C.

Volltext

Pharmacokinetics of albumin-bound paclitaxel (ABX) in combination with temozolomide (TMZ) and oblimersen sodium (OBL) in patients with advanced melanoma von Seidman, M. J., Pavlick, A. C., Gandhi, A., Escalon, J., Madden, K., Staha, J., Yepes, E., Mendoza, S., Liebes, L. F.

Volltext

A phase I/II study to determine the feasibility and efficacy of the triple combination of oblimersen (OBL), abraxane (ABX), and temozolomide (TMZ) in metastatic melanoma and normal... von Pavlick, A. C., Escalon, J., Madden, K., Yepes, E., Staha, J., Ryan, T., Buckley, M. T., Mendoza, S., Yee, H., Liebes, L. F.

Volltext

Results of a phase I study of fixed dose rate gemcitabine /irinotecan (FIGI) von Ryan, T., Hochster, H., Escalon, J., Muggia, F. M.

Volltext

Results of a phase I study of fixed dose rate gemcitabine /irinotecan (FIGI) von Ryan, T., Hochster, H., Escalon, J., Muggia, F. M.

Volltext

Phase II study of cetuximab in mucinous peritoneal carcinomatosis von Andreopoulou, E., Muggia, F., Safa, M., Escalon, J., Downey, A., Newman, E., Hochster, H., Wojtaszek, C., Mauro, D., Lowy, A.

Volltext

Phase I study of bortezomib and oxaliplatin (BOX) in solid tumors: Improved neurotoxicity (NT) profile with lower bortezomib (B) dose von Kosloff, R. A., Wright, J., Ivy, P., Escalon, J., Norwood, B., Levinson, B., Pavlick, A. C., Beric, A., Muggia, F. M., Hochster, H.

Volltext

Phase I dose-escalating study of bi-weekly pemetrexed (MTA) with fixed dose rate gemcitabine (gem) in patients with advanced cancer von Chen, A. L., Ryan, T., Muggia, F., Chachoua, A., Escalon, J., Moore, S., Haniff, F., Levinson, B., Nicol, S., Hochster, H.

Volltext